Skip to main content
Sign In
 

Kevin Deane MD

Assistant Professor of Medicine


Dr Kevin Deane is currently working on a large-scale study to understand how genetic and environmental factors influence the development of rheumatoid arthritis, and how blood-based markers can be used to predict the future onset of rheumatoid arthritis. He is also investigating how specific areas of the body, such as the lung, contribute to the development of autoimmunity. Additionally, in cooperation with a Colorado-based non-profit health-fair organization, Dr. Deane is investigating approaches to screening the population for undiagnosed rheumatoid arthritis, and how such screening can be used to identify people that may be at risk for rheumatoid arthritis in the future. In his clinical practice, Dr. Deane is interested in the management of a wide-variety of autoimmune diseases including rheumatoid arthritis and lupus.

 

 

 

 

2002-Present Ph.D. Candidate Clinical Science University of Coloardo School ofMedicine
2001-2004 Fellowship (Rheumatology) University of Colorado
1998-2000 Residency (Internal Medicine) University of Colorado
1997-1998 Internship (Internal Medicine) University of Colorado
Medical School 

Loma Linda University School of Medicine, Loma Linda, California

 

2006-Present Assistant Professor of Medicine, Division of Rheumatology, University of Colorado Denver
2004-2006 Instructor, Division of Rheumatology, University of Colorado, Denver, CO
2000-2001 Chief Medical Resident, University of Colorado Denver, Denver, CO
1999, 2001   Golden Apple Teaching Award, University of Colorado

Research Interests:

My research interests are in the pre-clinical identification of autoimmune disease. I am currently involved as a co-investigator in a multi-centered NIH sponsored study investigating the relationship between genetics, environmental exposures, and the development of rheumatoid arthritis-related autoimmunity. In addition, I have special interest in building models for the prediction of future development of autoimmune disease.

 

 

SELECTED PUBLICATIONS:

1. Ferucci ED, Majka DS, Parrish LA, Moroldo MB, Ryan M, Passo M, Thompson SD, Deane KD, Rewers M, Arend WP, Glass DN, Norris JM, Holers VM. Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 2005 Jan;52(1):239-46.

2. Deane KD, West SG. Antiphospholipid Antibodies as a Cause of Pulmonary Capillaritis and Diffuse Alveolar Hemorrhage: A Case Series and Literature Review. Sem Arthritis Rheum 2005;35:154-165.

3. Bhatia SS, Majka DS, Kittelson JM, Parrish LA, Ferucci ED, Deane KD, Arend WP, Rewers M, Holers VM, Norris JM. Rheumatoid factor seropositivity is inversely associated with oral contraceptive use in women without rheumatoid arthritis. Ann Rheum Dis. 2006 Jul 25; [Epub ahead of print]

4. Young KA, Parrish LA, Zerbe GO, Rewers M, Deane KD, Michael Holers V, Norris JM. Perinatal and early childhood risk factors associated with rheumatoid factor positivity in a healthy paediatric population. Ann Rheum Dis. 2007 Feb;66(2):179-83

5. Majka DS, Deane KD, Parrish LA, Lazar AA, Barón AE, Walker CW, Rubertone MV, Gilliland WR, Norris JM, Holers VM. The duration of pre-clinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis. Ann Rheum Dis. 2007 Nov 1; [Epub ahead of print]

 

6. FitzGerald J, Mandl LA, Cron RQ, Lacaille D, Deane K, Franchin G, Lim SS, Park CC. Rheumatology fellows’ perception n training and careers in academia: The American College of Rheumatology Fellow Research and Academic Training Survey. Arthritis Rheum 2009;61(2):266-273.

7. Feser M, Derber LA, Deane KD, Lezotte DC, Weisman MH, Buckner JH, Mikuls T, O’Dell J, Gregersen PK, Holers VM, Norris JM. Plasma 25,OH vitamin D levels are not associated with rheumatoid arthritis-related autoantibodies in individuals at elevated risk for rheumatoid arthritis. J Rheumatol. 2009 May;36(5):943-6. Epub 2009 Mar 13.

8. Gizinski AM, Mascolo M, Loucks JL, Kervitsky A, Meehan RT, Brown KK, Holers VM, Deane KD. Rheumatoid arthritis(RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent RA. Clin Rheumatology, 2009;28(5):611-13.

9. Kolfenbach JR, Deane KD, Derber LA, O’Donnell C, Weisman MH, Buckner JH, Gersuk VH, Wei S, Mikuls TR, O’Dell JR, Gregersen PK, Keating RM, Norris JM, Holers VM. A prospective approach to investigating the natural history of pre-clinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA. Arthritis Rheum. 2009 Dec 15;61(12):1735-42.

10. Deane KD, Striebich CC, Goldstein BL, Derber LA, Parish MC, Feser ML, Hamburger EM, Brake S, Belz C, Goddard J, Norris JM, Karlson EW, Holers VM. Identification of Undiagnosed Inflammatory Arthritis in a Community Health-Fair Screen. Arthritis Rheum. 2009 Dec 15;61(12):1642-9

11. Deane KD, Norris JM, Holers VM. Pre-clinical rheumatoid arthritis: Identification, evaluation and future directions for investigation. Rheum Dis Clin North Am. 2010 May;36(2):213-41.

12. Ercan A, Cui J, Chatterton DE, Deane KD, Hazen MM, Brintnell W, O'Donnell CI, Derber LA, Weinblatt ME, Shadick NA, Bell DA, Cairns E, Solomon DH, Holers VM, Rudd PM, Lee DM. IgG galactosylation aberrancy precedes disease onset, correlates with disease activity and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum. 2010 Apr 29. [Epub ahead of print]

13. Kolfenbach, J.R., Deane, K.D., Derber, L.A., O’Donnell, C.I., Rosen, A., Darrah, E., Norris, J.M., and Holers, V.M. Autoimmunity to Peptidyl Arginine Deiminase Type 4 Precedes Clinical Onset of Rheumatoid Arthritis. Arthritis Rheum. 2010 May 23. [Epub ahead of print]

BOOK CHAPTERS/INVITED REVIEWS:

1. Deane KD, West SG.  Differential diagnosis of the crystal-induced arthropathies: acute monarthritis.  In: Crystal-Induced Arthropathies: Gout, Pseudogout, and Apatite-Associated Syndromes.  Wortmann RL et al, editors. Taylor & Francis Group, New York, 2006. pp 135-156.

2. Deane KD, West SG. Increased effectiveness in the newer rheumatoid arthritis therapies. Journal of Musculoskeletal Medicine 2006;23(3):171-180.

3. Deane KD. Managing co-morbidities in rheumatoid arthritis. J Musculoskeletal Medicine 2006;23(11):S24-S31.

4. Deane KD. Preventing and managing osteoporosis in rheumatoid arthritis. J Musculoskeletal Medicine 2006;23(12):838-844.

5. Deane KD. Adamantiades-Behcet’s Disease. In: Head and Neck Manifestations of Systemic Disease. Harris JP, Weisman M, editors. Informa Healthcare USA, Inc, 2007:27-40

6. Deane KD, West SG. Other traditional disease-modifying antirheumatic drugs: monotherapy and combination therapy. In: Rheumatoid arthritis. Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Mosby, Elsevier, Philadelphia, PA, USA, 2009:325-336.

7. Deane KD. Bursitis, Tendinitis, Myofascial Pain, and Fibromyalgia. In: Conn’s Current Therapy 2009. Rakel RE and Bope ET, editors. Saunders, Elsevier, Philadelphia, PA, USA, 2009:994-998.